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Perinatal infection with a temperature-sensitive mutant (ts-1) of Moloney murine leukemia virus (MoMuLV) results in massive splenomegaly and thymomegaly in mice and development of lymphoma in .55 % of infected pups. Previous flow cytometry studies showed a decrease in CD4
+ cells in perinatally infected pups, but cell population changes in infected animals with lymphoma compared with infected animals without lymphoma has not yet been reported. In the current study, BALB/c mice were infected with ts-1 through breast milk transmission and observed until development of clinical signs and symptoms of lymphoma and/or symptomatic ts-1 infection. Flow cytometry studies were performed on blood, spleen and thymus samples and correlated with gross morphology and histological changes, resulting from the development of lymphoma. Infected animals with lymphoma had significant decreases in CD4 + and CD8 + cell counts in blood and spleen compared with controls. The spleens of infected animals without lymphoma showed a decrease in CD4 + and CD8 + cell counts, but this was not significant compared with controls. In the thymus, CD4 + and CD8 + cell counts also decreased, but this was not significant in infected animals with and without lymphoma compared with controls. Markers of myeloid cell dysfunction increased in the thymus of animals with infection with and without lymphoma compared with controls. Thus, immunosuppression and CD4
INTRODUCTION
Moloney murine leukemia virus (MoMuLV) is a neurocytopathic mammalian C-type virus that causes an AIDSlike syndrome in infected mice with many similarities to human immunodeficiency virus (HIV) infection in humans (Clark et al., 2001) . A temperature-sensitive mutant, ts-1, of MoMuLV has been developed (Wong et al., 1973) . When neonatal BALB/c mice of ,10 days of age are injected intraperitoneally with ts-1, clinically apparent infection develops within 10 weeks. This clinical syndrome is characterized by progressive hind-limb paralysis, severe body wasting, thymic and splenic atrophy, and immunodeficiency (Wong, 1990; Wong et al., 1989) . As in HIV infection in humans, immunodeficiency is associated with CD4 + cell apoptosis , 1992a Saha et al., 1994) .
Macrophages and CD4
+ and CD8 + cells are susceptible to infection (Saha & Wong, 1992b) . Clinical manifestations and the severity of disease can be modified by altering the murine strain used, the age at inoculation (up to 10 days of age), the dose of the inoculant and the route of infection (Chakraborty et al., 2003) .
Our laboratory was the first to develop ts-1 as a smallanimal model for mother-to-pup retrovirus transmission and to identify the unique characteristics of perinatal ts-1 infection compared with intraperitoneal infection (Chakraborty et al., 2003; Clark et al., 2001; Duggan et al., 2004 Duggan et al., , 2006 . Perinatal transmission occurs at a rate of 39.6 % in utero, 78 % for combined in utero/intrapartum exposure and 99 % for combined in utero/intrapartum/post-partum exposure (Duggan et al., 2004) . Exposure to infected breast milk alone from an infected surrogate mother results in infection in 97 % of uninfected pups (Duggan et al., 2004) . Mice infected through perinatal transmission and via breast milk have massive enlargement of the spleen and thymus, which is significantly different from the splenic and thymic atrophy seen as a result of intraperitoneal infection (Wong, 1990) . In addition, when pups acquire ts-1 infection through breast milk exposure, lymphoma occurs at a rate of up to 55 % (Chakraborty et al., 2008 (Chakraborty et al., , 2011 . In the intraperitoneal infection model, lymphoma is rarely seen (Wong, 1990) . The reason for lymphomagenesis via breast milk transmission and not through blood-borne routes remains unclear.
Flow cytometry studies on ts-1 acquired through perinatal transmission by our laboratory previously have shown decreases in CD4
+ and CD8 + cell counts in pups infected through breast milk transmission alone without significant changes in CD4
+ /CD8 + cell levels compared with controls in animals infected by the in utero/intrapartum route (Duggan et al., 2006) . Other flow cytometry studies on ts-1 have been limited and have been performed mainly on pups infected by intraperitoneal injection (Wong, 1990) . These pups have splenic and thymic atrophy without the development of lymphoma. In one study on intraperitoneally infected mice, at days 35-40 the CD4 + count had a mean value of 50.6 % in uninfected FVB/N mice compared with 33.3 % in infected animals. The levels of CD8 + cells did not change significantly over this time period (from 13.1 to 14.9 %; Saha & Wong, 1992b) . The goal of the current study was to examine the changes in CD4 + , CD8
+ and myeloid cell populations in blood, spleen and thymus samples by flow cytometry in mice infected via breast milk exposure and to correlate these changes with the observed clinical disease processes.
RESULTS

Gross appearance and histology
Mice were divided into four groups (see Methods): group 1 comprised pups suckled from their experimentally infected biological mothers; group 2 was pups suckled from experimentally infected surrogate mothers, group 3 comprised pups suckled from control uninfected biological mothers and group four was pups suckled from surrogate control uninfected mothers. Mice were observed for up to 14 months or until they reached a morbid stage and were then euthanized. The mice were divided into three groups for further analysis: control (no infection), infected with no lymphoma and infected with lymphoma.
When the gross appearance of the control samples (Fig. 1a) was compared with that of infected samples (Fig. 1b) , the spleen and liver showed extensive enlargement. Organomegaly was correlated with organ weight, and splenomegaly was graded as representative of these conditions. Spleens were categorized into grades 1-4 based on weight as follows: normal (grade 1, ,0.2 g), moderate enlargement (grade 2: ¢0.2 to ,0.5 g), severe enlargement (grade 3: ¢0.5 to ,1.0 g) and morbid enlargement (grade 4: .1.0 g) (Fig. 1b) .
For the control mice (groups 3 and 4), 98. Varying degrees of abnormalities were evident in the splenic histology with the progression of disease and organomegaly. Representative splenic morphology is depicted in Fig. 2 . Fig. 2 (a) is a section of the spleen from a control animal, which showed normal histology with normal white and red pulp. The white pulp consisted of lymphocytes in a cylindrical sheath surrounding the central arteriole and the red pulp consisted of sinusoids. Fig. 2 (b) shows that there was increasing loss of the normal architecture of white and red pulp in infected spleens. Spleens with even moderate enlargement often showed complete absence of the normal architecture of the spleen tissue and cellular invasion and replacement ( Fig. 2b) . At a higher magnification (Fig. 2c) , these cells could be seen to have multiple or lobulated nuclei. In the histology of grade 4 spleens, however, the number of giant multinucleated cells decreased in the morbidly enlarged spleen and these cells, where found, were located towards the splenic interior.
Flow cytometry
Peripheral blood and spleen and thymus tissues were evaluated by flow cytometry to determine the different cell populations. Flow cytometry was run on representative individual samples from mice in groups 1-4.
Red blood cells (RBC), white blood cells (WBC), platelets and haemoglobin. Peripheral blood sample profiles showed a general decrease in all fractions except WBCs in infected mice with lymphoma (mean value: 10.49610 3 ml
21
) when compared with control WBC counts (4.93610 3 ml
). Decreases were significant (P,0.05) for WBCs and haemoglobin in the infected/no lymphoma group, whereas in the infected/lymphoma group, the decrease was significant for RBCs (39.88610 5 ml
) and haemoglobin (6.1 g dl ). However, these changes were not statistically significant.
Lymphocytes, monocytes and granulocytes. Table 1 shows that there was an overall significant decrease in lymphocyte count in blood samples in the infected/no lymphoma group (5.57 %) and infected/lymphoma group (14.18 %) compared with the control group (31.99 %). A similar trend for lymphocytes was observed in the spleen of animals with infection/no lymphoma (39.03 %) compared with the control group (53.27 %), although this was not significant. A decrease in the lymphocyte population in the spleen was significant in the infected/lymphoma group (21.40 %) compared with the control group (53.27 %). In the thymus, there was a decrease in the lymphocyte population of infected animals both with (20.50 %) and without (26.43 %) lymphoma compared with the controls (58.43%), and these decreases were significant (P,0.05).
In the blood, there was a decrease in monocytes and granulocytes of infected/no lymphoma animals compared with control animals (4.22 vs 7.51% and 19.01 vs 23.62%, respectively) versus an increase in infected/lymphoma animals (13.87 and 25.87 %, respectively). These changes were not significant (P.0.05). Some increases were observed in the populations of monocytes and granulocytes in the spleen and thymus. Monocytes in the spleen of control animals were present at 9.15 % compared with 9.93 % for the infected/no lymphoma group and 13.64 % for the infected/lymphoma group. Granulocytes in the spleen of control animals were present at 14.65 % compared with 16.93 % for infected/no lymphoma mice and 28.98 % for infected/lymphoma mice. These changes were also not significant (P.0.05). In the thymus, the monocyte and granulocyte populations of control animals increased in infected/no lymphoma mice (from 6.45 to 7.85 % and from 6.91 to 10.6 2%, respectively). Further increases in the same populations occurred in infected/lymphoma animals (from 6.45 to 12.88 % and from 6.91 to 24.45 %). The latter changes were significant (P,0.05).
T-and B-lymphocyte subsets. Table 2 and Fig. 3 show that there were significant changes in the subpopulations of the T-and B-lymphocyte populations in blood samples from control and infected mice. The mean percentage of CD4 +
CD3
+ cells in control mice was 14.59 %, compared with 2.71 % in the infected/no lymphoma group and 3.55 % in the infected/lymphoma group. The mean level of CD8 +
+ cells was 4.54 % in control mice in comparison with 0.58 % in infected/no lymphoma and 1.65 % infected/ lymphoma. All the above changes were significant. The Bcell population (CD19 + CD74 + ) decreased in both the infected/no lymphoma and infected/lymphoma groups, but only reached statistical significance in the infected/no Table 3 . In the blood, there were decreases in these two cell populations for the infected/no lymphoma group (0.62 and 1.06 %, respectively) compared with the control group (0.88 and 2.07 %). In animals developing lymphoma, there was a sharp increase in the same cell populations (2.63 and 5.84 %, respectively) compared with the control group. These changes, although not statistically significant, were quite distinct (Table 3 , Fig. 4a, b) . In the spleen, similar decreases were observed in the infected/no lymphoma group for markers Gr-1 + CD74 + and CD11b + F4/80 + (1.36 and 4.89 %, respectively) compared with the control group (2.22 and 7.34 %, respectively). The change in level of the myeloid indicator CD11b + F4/80 + was statistically significant (Table 3) . The thymus showed increases in these cell populations indicative of myeloid dyscrasias for both the infected/no lymphoma and infected/ lymphoma groups compared with the control group. In the infected/no lymphoma group, the mean increases in markers Gr-1 + CD74 + and CD11b + F4/80 + were 0.68 and 8.64 % compared with 0.14 and 0.87 %, respectively, in the control group. In the infected/lymphoma group, the mean values for the same cell populations increased further (1.59 and 10.20 %) compared with the control group and were statistically significant.
DISCUSSION
Infection with ts-1 virus results in an immunodeficient state in mice, with many similarities to HIV infection in humans. The perinatal route of transmission results in additional similarities to AIDS, including splenomegaly and lymphoma. Immunosuppression is a known risk factor in the development of lymphoma in patients with HIV, with the incidence increasing with the degree of CD4 + cell loss (Biggar et al., 2007; Bower et al., 2009 ).
However, in previous in vivo experiments with ts-1 infection by intraperitoneal injection, lymphoma was a rare event, regardless of the observation period or degree of immunosuppression (Wong, 1990) . In this experiment, the incidence of lymphoma may have been higher than reported previously because initial inoculation with the pathogen was lengthened to 72 h after delivery rather than 24 h, and the animals were allowed to live until the onset of Pathogenesis of retrovirus-induced lymphoma disease symptoms and morbidity. Therefore, the route, dose, timing and duration of infection are related to lymphoma development. Thus, a one-time, large-dose intraperitoneal injection of ts-1 causes an acute disease state and the animals die within 32-40 days of infection (Wong, 1990) . In contrast, continuous, slow infection via breast milk for 19 days (until weaning in the present study), causes a chronic disease state, as thymic development progresses during the perinatal period leading to lymphoma development. As the thymus does not fully develop before birth, it is important to understand the host-virus interaction during development of the thymus in the perinatal period. Many conditions including virus infection can affect T-cell development and maturation of T-cells in the thymus, which need further investigation. Thymic lymphoma takes a much longer time period to develop, which we suspected in our ts-1-infected mouse model. These perinatal/timing results in virus-induced lymphoma are a major finding of our investigation.
According to Wong et al. (1991) , ts-1 causes severe thymic atrophy in FVB/N mice because of its ability to replicate in the thymus at a greater rate in comparison with a constructed chimaeric virus, ts-1 Cas(NS). This chimaeric virus did not cause as much thymic atrophy as ts-1 but was as neurovirulant as ts-1. High ts-1 replication in thymus and neural tissues makes this virus a very good candidate for studies of immune/neural networks and their disorders. Prasad et al. (1989) used homozygote BALB/c nude (nu/nu) mice, their heterozygote (+/nu) littermates and normal BALB/c (+/+) mice for their ts-1 infection study. Their short-term (24-48 h), single-dose infection study caused severe pathological changes in the central nervous system and paralysis in +/nu and +/+ mice but only mild to moderate effects on the central nervous system pathology in nu/nu mice. When nude mice were reconstituted with Tcells, these mice developed paralysis and neurodegeneration. They concluded that the thymus and/or mature thymocytes are important for neurodegeneration. In the current study, we confirmed that almost 100 % of infected mice with or without lymphoma developed a neurological disorder, indicated by hind-limb tremors and paresis leading to paralysis. We also observed other clinical manifestations, including kyphosis and body wasting, as observed by Wong (1990) .
Flow cytometry was used to evaluate different cell populations in the harvested tissues using various markers to compare control mice with infected mice with and without lymphoma. Blood samples and spleen and thymus tissues were evaluated. Infected mice with lymphoma demonstrated increases in their WBC populations in the spleen and thymus and decreases in RBCs. Infected mice with and without lymphoma had a more profound lymphopenia and loss of T-and B-cell subpopulations in blood, spleen and thymus tissues compared with control mice.
Statistically significant CD4 + cell decreases occurred in the blood of infected mice with no lymphoma and in the blood, spleen and thymus of infected mice with lymphoma compared with CD4 + cell levels of control mice. CD8
+ and CD19 + cell decreases were significant in the blood of infected mice with lymphoma versus control mice.
Markers of myeloid cell dysfunction, as denoted by Gr-1 +
CD74
+ and CD11b + F4/80 + cells (Diao et al., 2011; Pulendran et al., 1997) , increased in the blood of infected animals with lymphoma but decreased in infected animals with no lymphoma. In splenic tissues, the same trend of a decrease for infected/no lymphoma mice and a return to normal values for infected/lymphoma mice was observed. In the thymus, however, there was a population increase for both the infected/no lymphoma and infected/lymphoma groups. In the latter case, the increase was significant. The population increases for cells with these markers are an accepted indicator for leukaemia and other malignancies (Craig & Foon, 2008) , and were observed in our experiment for blood, thymus and spleen samples. In studies of BALB/c and C57BL/6 transgenic mice with malignancies, Gr-1 + subpopulations significantly decreased in multiple tumour types (Diao et al., 2011) . This was also associated with alterations in T-cell anti-tumour responses. The role of the thymus in lymphomagenesis in this animal model requires further delineation.
In conclusion, MoMuLV ts-1 infection caused organomegaly and malignant changes in splenic tissues when the route of infection was by the peripartum route rather than the intraperitoneal route. Flow cytometry analysis further elucidated changes in subpopulations of the cells between control mice and infected mice with and without lymphoma. As organomegaly and malignant changes progressed, cell populations with myeloid markers increased and cell populations with CD4, CD8 and CD19 markers decreased. The degree of immunosuppression and development of malignancy may be directly related to the loss of Tand B-cell populations, and the increase in myeloid cell population dysfunction.
METHODS
MoMuLV ts-1 viral stock and 15F cell assay. Virus culture and the virus assay methodology were as described previously (Chakraborty et al., 2003; Wong et al., 1973) . The MoMuLV ts-1 stock, thymus/bone marrow (TB) cells for virus culture and 15F cells for the virus assay were provided by Dr P. K. Y. Wong (University of Texas, MD Anderson Cancer Center, Smithville, TX, USA). Briefly, ts-1 virus was grown in TB cells cultured in Dulbecco's modified Eagle's medium (DMEM) with 6 % FCS, 4 % newborn calf serum and 1 % penicillin/streptomycin at 37 uC until 70-80 % confluency was reached. The TB cells were then treated with Polybrene in DMEM containing 3 % heat-inactivated newborn calf serum and 1 % penicillin/streptomycin overnight at 37 uC. The ts-1 virus [1610 6 focus-forming units (f.f.u.) ml 21 ] was then added to cells, and the cell suspension with virus was incubated at 34 uC for 40 min. The cells were then cultured in fresh DMEM at 34 uC for 3 days or until 70-80 % confluency was achieved. Culture medium containing the virus particles was removed, filtered through a 0.45 mm filter and stored in 1 ml aliquots at280 uC.
15F cells were grown for the virus assay as described above for TB cells. Cells (9.6610 6 ml 21 ) were plated onto 60 mm culture plates in Polybrene. Serial dilutions of 0.2 ml virus stock or serum to be assayed for virus quantification were added to 24-well plates. Next, 0.5 ml of corresponding virus dilutions was transferred to 60 mm plates and incubated at 34 uC for 40 min. The medium was aspirated and the cells incubated in fresh DMEM for 3 days at 34 uC. Fresh DMEM was added after 3 days and the cells incubated again for 2-3 days at 34 uC. The number of f.f.u. on the plates was determined. A final virus concentration was obtained for the virus stock, which was diluted to 4.0610 6 f.f.u. ml 21 for use.
Mice. Forty-one BALB/c timed pregnant female mice purchased from Charles River Laboratories were used in the study. Seventy female pups produced by these mice were used for the experiment and the males discarded. At 72 h after birth, the uninfected female pups were divided into two groups of 40 experimental and 30 control mice. Each of the 40 females of the experimental group was injected intraperitoneally with 0.2 ml ts-1 virus at a concentration of 4.0610 6 f.f.u. ml
21
. The remaining 30 females were each injected with 0.2 ml DMEM intraperitoneally and served as the control group. After maturity, these female mice were placed in cages with uninfected male mice at a 3 : 1 ratio of females:males until pregnancy occurred. Within 12 h of birth, pups from the infected and control groups were divided into four groups to suckle from either surrogate or biological mothers (infected or control groups). A total of 355 pups were divided into two experimental and two control groups: group 1 pups consisted of 96 mice infected via biological mother's breast milk and indicated in utero, intrapartum and post-partum modes of infection; group 2 consisted of 98 mice infected via surrogate mother's breast milk to assess combined intrapartum and post-partum modes of infection; and groups 3 and 4 were the controls with similar modes of suckling, respectively. Pups were left until weaning at 19 days. Mice were then observed for up to 14 months or until they reached a morbid stage, indicated by an enlarged spleen and other clinical symptoms. The mice were then injected with heparin and euthanized. At the same time, a similar number of control mice were euthanized. At the time of euthanasia, blood, spleen and thymus tissue samples were obtained. The tissues were used for gross and histological analysis and flow cytometry studies. MoMuLV ts-1 infection was confirmed by PCR analysis detecting the presence of viral genome (Duggan et al., 2004) . The mice were divided into three groups for analysis: control (no infection), infected with no lymphoma and infected with lymphoma. The spleens were categorized into grades 1-4 based on weight data and further categorized by degree of pathogenicity (see Results).
Histology. Histological tissue preparation was carried out by a standard procedure. Tissue samples of 3-5 mm were fixed in 100 % neutral-buffered formalin, dehydrated, embedded in paraffin and sectioned. Slides were stained with haematoxylin and eosin for microscopic examination.
Flow cytometry. Peripheral blood, spleen and thymus samples were obtained at the time of euthanasia and prepared for flow cytometric analysis. Briefly, blood was collected, the RBCs were depleted and cells were stained for flow cytometry. The samples were washed with Dulbecco's PBS (DPBS; pH 7.2) with 2 % heat-inactivated FCS and 0.1 % sodium azide (Sigma). Cell suspensions of splenic and thymic tissues in DPBS were passed through a 50 mm filter and the samples were lysed and washed with DPBS as above. mAbs were used for flow cytometry on a FACSCalibur flow cytometer (Becton Dickinson) following the manufacturer's instructions. Mouse mAbs for the following were evaluated: CD4/CD3/CD45/CD8, CD74/CD19/CD45/ Gr-1 and F4/80/CD13/CD45/CD11b. Appropriate isotype controls were tested for each analysis. At least 5000 events were collected in the
